NCT00629044View on ClinicalTrials.gov

Genetic Polymorphysm of Cholesterol 24 S Hydroxylase in Patients With Glaucoma and AMD

NACompletedINTERVENTIONAL
Enrollment

320

Participants

Timeline

Start Date

November 30, 2007

Primary Completion Date

November 30, 2009

Study Completion Date

January 31, 2011

Conditions
Glaucoma
Interventions
BIOLOGICAL

Assessing the blood level of cholesterol 24 S Hydroxylase

Comparison of venous blood level of Cholesterol 24 S hydroxylase and 24 hydroxycholesterol in patients with Glaucoma and AMD and in healthy subjects.

BIOLOGICAL

Assessing the blood level of cholesterol 24 S hydroxylase

Comparison of venous blood level of cholesterol 24 S hydroxylase and 24 hydroxycholesterol in patients with Glaucoma, AMD end in healthy subjects

BIOLOGICAL

assessing the blood level of cholesterol 24 S hydroxylase

Comparison of venous blood level of cholesterol 24 S hydroxylase and 24 hydroxycholesterol in patients with glaucoma, AMD and in healthy subjects

Trial Locations (1)

21000

Ophthalmology Unit CHU Dijon, Dijon

All Listed Sponsors
lead

Centre Hospitalier Universitaire Dijon

OTHER

NCT00629044 - Genetic Polymorphysm of Cholesterol 24 S Hydroxylase in Patients With Glaucoma and AMD | Biotech Hunter | Biotech Hunter